FDA approves Vir Biotechnology antibody drug for emergencies
George Scangos, President and CEO of Vir Biotechnology, joined Yahoo Finance's Julia LaRoche and Adam Shapiro to discuss the latest on the company's COVID-19 antibody treatment.
Curated by Pension Times Finance Experts
· 1 min readAdvertisement
WHAT TO WATCH NEXT...